Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
Emerging data suggest suboptimal antibody responses to COVID-19 vaccination in patients with hematological malignancies. We evaluated the humoral response following the BNT162b2 vaccine in patients with chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), and Hodgkin’s lymphoma (HL). An...
Main Authors: | Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Chara Giatra, Ioannis Asimakopoulos, Maria Dimou, Aimilia D. Sklirou, Ioannis Ntanasis-Stathopoulos, Ismini Darmani, Alexandros Briasoulis, Efstathios Kastritis, Maria Angelopoulou, Ioannis Baltadakis, Panayiotis Panayiotidis, Ioannis P. Trougakos, Theodoros P. Vassilakopoulos, Maria Pagoni, Meletios A. Dimopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4480 |
Similar Items
-
Hodgkin Lymphoma Mimicking Osteomyelitis
by: Aneela Majeed, et al.
Published: (2017-06-01) -
Hodgkin Lymphoma Mimicking Osteomyelitis
by: Majeed, Aneela, et al.
Published: (2017) -
Use of rituximab in NHL malt type pregnant in I° trimester for two times
by: Sica Antonello, et al.
Published: (2019-11-01) -
The Demographic and Clinical Properties of Patients Associated With NHL Between 1999 and 2005
by: M. Nuri Özbek, et al.
Published: (2006-01-01) -
Atypical presentation of Non-Hodgkin Lymphoma (NHL): a case report
by: Fabiola Mastropietro, et al.
Published: (2014-12-01)